Lars M. Wagner, MD, was recently named the new chief of the Division of Hematology-Oncology in the Department of Pediatrics, effective July 9, 2018.
Dr. Wagner earned his medical degree at the University of Kentucky College of Medicine and completed his pediatrics residency at Le Bonheur Children’s Medical Center in Memphis, Tennessee. He completed his pediatric hematology/oncology fellowship at St. Jude Children’s Research Hospital. Following faculty appointments at the University of Utah and the University of Cincinnati, he has spent the last five years as professor of pediatrics and chief of the Division of Pediatric Hematology/Oncology, and Children’s Miracle Network Research Chair in Pediatrics at the University of Kentucky.
Dr. Wagner’s clinical and translational research is primarily focused on solid tumors. He has led national phase I and II trials through the Children’s Oncology Group as well as the New Approaches to Neuroblastoma Therapy Consortium and the National Pediatric Cancer Foundation. Specifically, he is interested in the development of combination therapies for sarcoma, which couples well with his clinical interests, including sarcoma and pediatric brain tumors.
"Dr. Wagner’s impressive strengths as a researcher, clinician, educator and mentor make him the ideal leader for our pediatric hematology/oncology efforts, and we are fortunate that he will be serving in this new role in the department," says Ann M. Reed, MD, William Cleland Professor of Pediatrics, chair of the Department of Pediatrics, and physician-in-chief of Duke Children's.